Investeringsforeningen Multi Manager Invest
7.4.2026 13:32:02 CEST | Globenewswire | Press release
Investeringsforeningen Multi Manager Invest - ophævelse af suspension
Investeringsforeningen Multi Manager Invest - ophævelse af suspension
I fortsættelse af tidligere meddelelse d. 7. april 2026 skal det herved oplyses, at det nu igen er muligt at stille indre værdier i nedenstående afdelinger, hvorfor Nykredit Portefølje Administration A/S har anmodet Nasdaq Copenhagen A/S om, at suspension ophæves.
Ophævelsen gælder nedenstående afdelinger:
| Fund Name | ISIN | Order Book Code |
| Nye Aktiemarkeder | DK0060316685 | MMINAM |
| Nye Aktiemarkeder Akk. | DK0060316768 | MMINAA |
| Globale Aktier | DK0060447274 | MMIGA |
| Globale Aktier Akk. | DK0060447357 | MMIGAA |
Eventuelle spørgsmål vedrørende denne meddelelse kan rettes til npa.pm@nykredit.dk eller CRH@nykredit.dk
Med venlig hilsen
Nykredit Portefølje Administration A/S
Tage Fabrin-Brasted
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
SERB Pharmaceuticals23.10.2026 21:01:27 CEST | Press release
SERB Pharmaceuticals Announces Positive Results from the Post-Authorisation Efficacy Study of Idefirix® (imlifidase) Presented at ASN Kidney Week 2026
F. Hoffmann-La Roche Ltd23.10.2026 19:30:00 CEST | Press release
Roche presents interim phase III data showing sefaxersen significantly reduced proteinuria in people with IgA nephropathy (IgAN)
TecDo Technology Co., Limited23.10.2026 18:37:22 CEST | Press release
TGC 2026: Tec-Do Launches Navos Pro for Results-Driven AI for Work
CGTN23.10.2026 18:17:10 CEST | Pressemeddelelse
CGTN: Hvad fortæller historien om 'Half a Quilt' (Et halvt vattæppe) os om Kinas nye lange march?
Genmab A/S23.10.2026 17:55:00 CEST | Press release
Genmab Announces Rinatabart Sesutecan (Rina-S®) Demonstrates Statistically Significant Improvement in Progression-Free Survival and Overall Survival in Patients with Platinum-Resistant Ovarian Cancer
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom